Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CASI Pharmaceuticals Inc CASI

Healthcare Biotechnology
CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its... see more

Recent & Breaking News (NDAQ:CASI)

Report: Exploring Fundamental Drivers Behind CASI Pharmaceuticals, Booking, Enstar Group, Madrigal Pharmaceuticals, Dermira, and Kaiser Aluminum — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire November 28, 2018

CASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi, China

PR Newswire November 16, 2018

CASI Pharmaceuticals Announces Third Quarter and First Nine Months 2018 Financial and Business Results

PR Newswire November 14, 2018

CASI Pharmaceuticals Acquires HBV ANDA from Laurus Labs Limited

PR Newswire October 23, 2018

CASI Pharmaceuticals Announces Appointment Of President To Its China Operations To Lead Commercialization

PR Newswire October 2, 2018

CASI Pharmaceuticals Announces Appointment Of Chief Financial Officer

PR Newswire September 28, 2018

CASI Pharmaceuticals Announces $48.5 Million Private Placement

PR Newswire September 14, 2018

CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results

PR Newswire August 14, 2018

CASI Pharmaceuticals Added To Russell 2000®, 3000® And Microcap® Indexes

PR Newswire July 3, 2018

Report: Exploring Fundamental Drivers Behind Cabot Oil & Gas, Chesapeake Lodging Trust, CASI Pharmaceuticals, Peabody Energy, Alcoa, and Edwards Lifesciences — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire June 25, 2018

CASI Pharmaceuticals Enters Strategic Partnering And Contract Manufacturing Agreement With Yiling Wanzhou International Pharmaceuticals For Entecavir And Cilostazol

PR Newswire June 21, 2018

CASI Pharmaceuticals To Present At The BIO International Convention

PR Newswire May 29, 2018

CASI Pharmaceuticals Announces First Quarter 2018 Financial And Business Results

PR Newswire May 15, 2018

Detailed Research: Economic Perspectives on CASI Pharmaceuticals, Energy Transfer Partners, Cypress Semiconductor, Xcel Energy, Ironwood Pharmaceuticals, and KalVista Pharmaceuticals — What Drives Growth in Today's Competitive Landscape

GlobeNewswire May 7, 2018

CASI Pharmaceuticals Announces Poster Presentation At The 2017 San Antonio Breast Cancer SymposiumTM (SABCS) On ENMD-2076 In Patients With Triple-Negative Breast Cancer (TNBC)

PR Newswire December 1, 2017

Global Biotechnology Market Showing Potential for Further Growth

PR Newswire November 21, 2017

CASI Pharmaceuticals Reports Third Quarter 2017 Financial Results

PR Newswire November 14, 2017

Cancer Immunotherapy Technology Projected to Create Further Growth

PR Newswire November 9, 2017

Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration, Roka Bioscience, VirnetX, and PhaseRx – Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire November 2, 2017

CASI Pharmaceuticals Announces $23.8 Million Registered Direct Offering Led By Existing Shareholders

PR Newswire October 13, 2017